Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelia

来源 :泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016 | 被引量 : 0次 | 上传用户:xdlclub
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To evaluate the clinical significance of lymphovascular invasion (LVI) on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection Methods: This retrospective study was performed with 155 patients with newly diagnosed pT1 urothelial carcinoma of bladder who were treated with transurethral resection of bladder tumor (TURBT) at our institution from January 2006 to January 2010.
其他文献
会议
会议
会议
Objective: Analyzing the features of transurethral end-fire greenlight photoselective vaporesection of prostate-shovel technique (PVRP-ST) and evaluating the safety and efficacy of transurethral end-f
Objective: Testicular nuclear receptor 4 (TR4) is a member of the nuclear receptor superfamily,which may play key roles to influence the metabolic diseases and prostate tumorigenesis.The purpose of ou
Objective: To investigate the impact of squamous and/ or glandular differentiation on recurrence and progression in patients with non-muscle-invasive urothelial carcinoma of bladder (NMIUCB) following
Objective: This study aimed to determine the expression status of actin-binding protein Girdin in non-muscle invasive bladder cancer (NMIBC) tissues,and to explore the relationships between Girdin exp
Objective: Prostate cancer is the second common malignancies ofmen around the world.According to the database about prostate cancer of our institute,in our study,we will analyses prostate cancer patie
Objective: To explore the feasibility of transurethral resection for the distal ureter and bladder cuff in radical nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma (UUT
Objective: To study the histology and pathology clinical features,diagnosis,identification and treatment of mixed epithelial and stromal tumor of the kidney (MESTK).